Friday, 1 August 2014

FDA approves Jardiance to treat type 2 diabetes

The U.S. Food and Drug Administration today approved Jardiance (empagliflozin) tablets as an addition to diet and exercise to improve glycemic control in adults with type 2 diabetes

No comments:

Post a Comment